Design and validation of a reporter mouse to study the dynamic regulation of TFEB and TFE3 activity through in vivo imaging techniques
Open Access
- 27 March 2024
- journal article
- research article
- Published by Taylor & Francis in Autophagy
- Vol. 20 (8) , 1879-1894
Abstract
TFEB and TFE3 belong to the MiT/TFE family of transcription factors that bind identical DNA responsive elements in the regulatory regions of target genes. They are involved in regulating lysosomal biogenesis, function, exocytosis, autophagy, and lipid catabolism. Precise control of TFEB and TFE3 activity is crucial for processes such as senescence, stress response, energy metabolism, and cellular catabolism. Dysregulation of these factors is implicated in various diseases, thus researchers have explored pharmacological approaches to modulate MiT/TFE activity, considering these transcription factors as potential therapeutic targets. However, the physiological complexity of their functions and the lack of suitable in vivo tools have limited the development of selective MiT/TFE modulating agents. Here, we have created a reporter-based biosensor, named CLEARoptimized, facilitating the pharmacological profiling of TFEB- and TFE3-mediated transcription. This innovative tool enables the measurement of TFEB and TFE3 activity in living cells and mice through imaging and biochemical techniques. CLEARoptimized consists of a promoter with six coordinated lysosomal expression and regulation motifs identified through an in-depth bioinformatic analysis of the promoters of 128 TFEB-target genes. The biosensor drives the expression of luciferase and tdTomato reporter genes, allowing the quantification of TFEB and TFE3 activity in cells and in animals through optical imaging and biochemical assays. The biosensor's validity was confirmed by modulating MiT/TFE activity in both cell culture and reporter mice using physiological and pharmacological stimuli. Overall, this study introduces an innovative tool for studying autophagy and lysosomal pathway modulation at various biological levels, from individual cells to the entire organism.Abbreviations: CLEAR: coordinated lysosomal expression and regulation; MAR: matrix attachment regions; MiT: microphthalmia-associated transcription factor; ROI: region of interest; TBS: tris-buffered saline; TF: transcription factor; TFE3: transcription factor binding to IGHM enhancer 3; TFEB: transcription factor EB; TH: tyrosine hydroxylase; TK: thymidine kinase; TSS: transcription start site.Keywords
Funding Information
- EU Joint Programme - Neurodegenerative Disease Research (GBA-PaCTS, 01ED2005B and GBA-PARK n. 212)
- P.C. and D.A.D.M. and by European Union—NextGenerationEU (PNRR M4C2-Investimento 1.4-CN00000041-PNRR_CN3RNA_SPOKE9)
- P.C. Publication costs supported by intramural funding (Department of Health Sciences, Università degli Studi di Milano, Milano, Italy)
This publication has 72 references indexed in Scilit:
- Drugging the undruggable proteins in cancer: A systems biology approachCurrent Opinion in Chemical Biology, 2022
- Transcription factor EB regulates cardiovascular homeostasisEBioMedicine, 2021
- Transcription factor EB: an emerging drug target for neurodegenerative disordersDrug Discovery Today, 2021
- Methods to Monitor and Manipulate TFEB Activity During Autophagy2017
- Transcription Factor EB Controls Metabolic Flexibility during ExerciseCell Metabolism, 2017
- The Transcription Factor EB (TFEB) Regulates Osteoblast Differentiation Through ATF4/CHOP‐Dependent PathwayJournal of Cellular Physiology, 2015
- Innate Host Defense Requires TFEB-Mediated Transcription of Cytoprotective and Antimicrobial GenesImmunity, 2014
- Bioluminescence based in vivo screening technologiesCurrent Opinion in Pharmacology, 2012
- Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular ClearanceDevelopmental Cell, 2011
- Systemic Delivery of DNA or siRNA Mediated by Linear Polyethylenimine (L-PEI) Does Not Induce an Inflammatory ResponsePharmaceutical Research, 2008